A n impressive amount of evidence has accumulated in recent years documenting the importance of strict diabetic control in forestalling the microvascular complications of diabetes mellitus. 1 " 4 This subject does not need to be reviewed here for readers of this journal. Although home glucose monitoring of capillary blood has been slowly gaining acceptance, 5 at present, the daily documentation of the degree of control in almost all diabetic patients is carried out by semiquantitative testing for glucosuria. Insulin-dependent patients usually test urine samples collected before each meal and their bedtime snack while some diabetic patients not taking insulin may test urine specimens collected within several hours of eating. In view of the data contained in references 1-3, the appropriate goal of therapy should be that all urine tests are negative for glucose. Bear in mind that glucosuria does not occur until plasma glucose concentrations exceed the renal threshold (T m ) for glucose, which corresponds to plasma glucose concentrations of 160-180 mg/dl in most individuals and even higher in older subjects and those with renal disease. Whether the patient routinely tests a first-or second-voided urine sample may bear importantly on the perceived degree of control. (For those who remain skeptical about the relationship between control and some of the complications of diabetes, I refer you to Figures 9, 10, and 11 in reference 3.)
Most diabetologists have usually recommended collecting and testing a second-voided urine specimen (and discarding the initial one without testing). The arguments for this position are as follows. The results of the second-voided specimen more accurately reflect the metabolic status at the time that the sample is collected. When compared with the prevailing plasma glucose concentration, the T m for glucose is evident. In addition, since the urine is not "contaminated" with glucose that may have been excreted into the bladder hours previously, the results of the second-voided specimen also more accurately reflect the effect of insulin acting at that particular time. The preprandial urine tests occur at times of peak insulin action depending on the time of injection and the type of insulin used (Table 1) . Therefore, the results are helpful in adjusting insulin doses.
On the other hand, missing postprandial glucosuria by only testing the second-voided specimen may lull the patient and the physician into a false sense of security that control is better than it really is. Glucosuria occurring after a meal should be appreciated and adjustments made to abolish it. A second and forceful argument against the routine requirement that the second-voided urine sample be tested is its impracticality. Many patients do not have or will not take the time to urinate twice before meals. Indeed, a survey of almost 1200 urine tests on the inpatient Diabetes Ward at Cedars-Sinai Medical Center, where testing of both first and second urines is allegedly part of the nursing routine, revealed that the second-voided specimen was not tested 45% of the time! If such poor adherence to this requirement is noted in such a highly structured environment, it is no wonder that our patients comply so poorly at home to testing double-voided urine samples.
One final point needs to be considered. How often will the results of testing the second-voided urine specimen yield information that differs from testing the first-voided sample? In 646 comparisons carried out in the survey at Cedars-Sinai Medical Center, the results were the same 72% of the time (Table 2) . Of those paired tests that differed, more glucosuria was noted in 23% of the first test and in only 5% of the second test. These results are similar to two other published studies ( Table 2 ). The higher percent of similar test results using Tes-Tape may be due to the fact that the last color change on the Tes-Tape strip depicts a large increase from Vi% to 2% glucosuria. Therefore, the results will be the same within a broad range of glucosuria. With the other two methods used in Table 2 , different results would be obtained at Vz%, 1%, and 2%. The high prevalence of the same results in first and second urine samples may not actually reflect similar amounts of glucosuria. Dilute urine (osmolalities < 100 mosm/kg) will cause falsely high results. 8 Most patients are instructed to drink 1-2 glasses of water after discarding their initial urine sample to aid in producing a second one. The effect of this procedure was assessed in second-voided urine samples collected 30 min after drinking 16 ounces of water in nine patients. 8 Falsely high results were found in all nine samples tested with Clinitest tablets, four of nine with Tes-Tape, five of nine with Clinistix, and four of nine with Diastix! In view of all these considerations, the following recommendations seem warranted. When diabetes is initially diagnosed and the patient is introduced to urine testing, routine testing of the second-voided urine with simultaneous measurements of plasma glucose levels should be performed until the T m for glucose is established. Once the T m has been determined, testing of a second-voided urine sample need only be done routinely before breakfast by patients who are taking intermediate-or long-acting insulin. Since this is often the time of the lowest glucose concentration during the 24-h period, it is important not to be misled by glucosuria which has occurred during the early part of the night and does not represent the true metabolic situation before breakfast. Insulin doses may be increased inappropriately based on the glucosuria of the first-voided specimen whereas the results of the second-voided sample would have dictated otherwise.
Although the same argument could be advanced for urine testing at other times, there is an important difference. During the day, the length of time between eating one meal and the preprandial urine test before the next one is much shorter than the time between the bedtime snack and the before breakfast test. Therefore, the difference between the postprandial glucose level (which peaks 1-2 h after eating) and the concentration before the next meal is more likely to be smaller than the one after the bedtime snack and before breakfast, 8-12 h later. For this reason, even if postprandial glucosuria is present in the next preprandial urine sample during the day, adjusting insulin doses based on the results of this test should not lead to overtreatment very often. In addition, and very importantly, tight control cannot be achieved if postprandial glucosuria is ignored. Therefore, during the day, only the first-voided urine specimen needs to be tested. Only in patients taking insulin should both the first-voided urine sample (on arising) and the second-voided specimen (before breakfast and before injecting insulin) be tested. Patients not receiving insulin need only test their first-voided urine samples at all times.
There is one other situation in which testing of a secondvoided sample may be important. In patients who are ill and taking supplemental amounts of regular insulin, basing a subsequent dose on a first-voided specimen could be inappropriate if the previous injection of insulin had been effective. The results of a second-voided specimen reflects the current metabolic status of the patient and should be used to decide if further short-acting insulin is necessary.
Therefore, in my view, routine testing of second-voided urine samples should be performed in only three situations: (1) to determine the T m for glucose; (2) before breakfast in patients receiving intermediate-or long-acting insulins; and (3) in sick patients who are taking supplemental amounts of regular insulin at home. First-voided urine samples should be routinely tested at all other times. In this manner, both improved patient compliance and tighter diabetic control should be easier to achieve.
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